Hansoh Pharmaceutical Group Company Limited
HNSPF
$5.20
$0.4910.40%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.48% | -10.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.48% | -10.51% | |||
| Cost of Revenue | -0.48% | -8.39% | |||
| Gross Profit | -0.48% | -10.72% | |||
| SG&A Expenses | -0.48% | 18.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.48% | -138.62% | |||
| Total Operating Expenses | -0.48% | 15.16% | |||
| Operating Income | -0.48% | -49.15% | |||
| Income Before Tax | -0.48% | -36.19% | |||
| Income Tax Expenses | -0.48% | -17.38% | |||
| Earnings from Continuing Operations | -0.48% | -38.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.48% | -38.90% | |||
| EBIT | -0.48% | -49.15% | |||
| EBITDA | -0.48% | -46.72% | |||
| EPS Basic | -0.52% | -38.99% | |||
| Normalized Basic EPS | -0.69% | -36.00% | |||
| EPS Diluted | -0.52% | -38.92% | |||
| Normalized Diluted EPS | 0.00% | -36.44% | |||
| Average Basic Shares Outstanding | 0.00% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.11% | |||
| Dividend Per Share | 0.00% | -30.23% | |||
| Payout Ratio | 0.00% | -- | |||